Literature DB >> 11912872

[Estrogen and progesterone receptors in meningiomas: immunohistochemical (Mib-1, p53) and clinico-morphological correlations].

G L Taddei1, A Caldarella, M R Raspollini, A Taddei, A M Buccoliero.   

Abstract

We studied 98 meningiomas including 89 benign, 5 atypical, and 4 anaplastic tumors to determine the immunohistochemical expression of estrogen and progesterone receptors and its prognostic value in comparison to histological grade, Mib-1 and p53. Estrogen and progesterone receptor positivity was observed in 63% and 5% of the cases, respectively. In 79% of meningiomas only a minimal proliferative activity was documented, whereas in 36% we detected an overexpression of the p53 oncoprotein. Anaplastic meningiomas were constantly negative for PgR, ER, and highly positive for Mib-1; 75% were positive for p53. A statistical correlation was demonstrated between p53 protein and Mib-1. Specifically the p53-negative meningiomas were frequently negative for Mib-1 (p = 0.002); conversely the lesions strongly positive for Mib-1 were p53-positive (p = 0.001).

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 11912872

Source DB:  PubMed          Journal:  Pathologica        ISSN: 0031-2983


  2 in total

1.  Periostin: a novel prognostic predictor for meningiomas.

Authors:  Yi Liu; Jin Shi; Ming Chen; Yong-fu Cao; Ya-wei Liu; Jun Pan; Song-tao Qi
Journal:  J Neurooncol       Date:  2014-12-18       Impact factor: 4.130

2.  Loss of heterozygosity of the p53 gene and deregulated expression of its mRNA and protein in human brain tumors.

Authors:  K Rohini; J Mathivanan; P D Antony Herold Prabhu; D K Subbakrishna; M L Gope; B A Chandramouli; S Sampath; B Anandh; R Gope
Journal:  Mol Cell Biochem       Date:  2006-12-16       Impact factor: 3.842

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.